论文信息 - Differentiation therapy for acute promyelocytic leukemia.

Differentiation therapy for acute promyelocytic leukemia.

Until recently, chemotherapy and hematopoietic stem-cell transplantation were the only therapeutic options in acute leukemia. The idea of restoring normal differentiation in primitive leukemic cell...

P. Fenaux | L. Degos

[1] C. Bloomfield,et al. All-trans-retinoic acid in acute promyelocytic leukemia. , 1997, The New England journal of medicine.

[2] C. Tribioli,et al. Acute leukemia with promyelocytic features in PML/RARα transgenic mice , 1997 .

[3] Wei Tang,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.

[4] P. Fenaux,et al. Acute promyelocytic leukemia: biology and treatment. , 1997, Seminars in oncology.

[5] P. Fenaux,et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group , 1993 .

[6] H. de Thé,et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. , 1993, Blood.

[7] R. Warrell,et al. Acute promyelocytic leukemia. , 1993, The New England journal of medicine.

[8] R. Warrell,et al. The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia , 1992, Annals of Internal Medicine.

[9] P. Fenaux,et al. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. , 1990, Blood.

[10] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.